Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.
Category: Clinical Trials
Can Prozac fight brain cancer?
The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.
Study finds convalescent plasma therapy ineffective for COVID-19
A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.
Stanford postdoc enters her youngsters in vaccine COVID trial
Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.
A cancer treatment that tackles heart disease?
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
Running clinical trials in a pandemic
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.
What COVID-19 has taught us about clinical trials
Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.
Stanford Medicine researchers work to stop COVID-19
Stanford Medicine researchers are investigating SARS-CoV-2 to address the COVID-19 pandemic and ultimately help restore normalcy to society.
Nation’s pediatricians push for safe, effective COVID-19 vaccines
Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.
Easier-to-use technology helps young people with type 1 diabetes
Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.
Many early COVID-19 studies have low-quality design, risk low-value evidence, research finds
Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds.
The race for a COVID-19 vaccine: What’s ahead
A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.
Stanford’s new Innovative Medicines Accelerator is already contributing to COVID-19 effort — and much more is planned
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
New cancer treatment that tracks and zaps tumors is coming to Stanford Medicine
Stanford Medicine will be the first to use a new technology that aims to heighten precision of radiation therapy in cancer patients.
Macular degeneration steals sight. A chip implant may get it back.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
Identification of “missing microbe” spurs clinical trial in ulcerative colitis
A study links ulcerative colitis to the depletion of important acids ordinarily produced by a set of gut microbes mysteriously missing in action.